Last updated: October 24, 2024
Sponsor: Kocaeli University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Kidney Cancer
Cancer/tumors
Renal Cell Carcinoma
Treatment
postopeartive controlled anlagesia with morphine
preoperative remifentanil consumption
Clinical Study ID
NCT05810571
KAEK / 12bl.01
Ages 18-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
ASA 1-3
open nephrectomy elective patients
BMI<35
Exclusion
Exclusion Criteria:
ASA 4-5-6
Laparoscopic nephrectomy
infection at the block side
coagulation disorder
BMI>35
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: postopeartive controlled anlagesia with morphine
Phase:
Study Start date:
October 24, 2024
Estimated Completion Date:
January 03, 2027
Study Description
Connect with a study center
Kocaeli University Medical Faculty
Kocaeli,
TurkeySite Not Available
Kocaeli University School of Medicine
Kocaeli, 41900
TurkeySite Not Available
Kocaeli University Medical Faculty
İzmit, 41100
TurkeyActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.